Former Soccer Star Mathieu Flamini Grows Bio-Tech Empire
The ex-Arsenal midfielder transitioned from professional sports to lead a multi-billion pound chemical company.
Updated on Oct. 15, 2026 in Soccer
Live Poll
Do you believe professional athletes should focus on business ventures during their playing careers?
Since co-founding GF Biochemicals in 2013, former professional footballer Mathieu Flamini has transitioned into a successful entrepreneur. The company, which mass-produces levulinic acid, is reportedly worth over £10 billion.
Why it matters
Flamini pursued the venture to address the negative environmental impact of human activity while seeking an intellectual escape from his daily athletic routine. His successful pivot highlights how athletes can leverage downtime during their careers to build significant industrial enterprises.
GF Biochemicals is reportedly valued at over £10 billion. During his professional football career, Flamini secured three FA Cups and reached the 2006 Champions League final.
The players
Mathieu Flamini
He is a retired French professional footballer who played for major clubs including Arsenal and AC Milan before shifting his focus to environmental biotechnology.
GF Biochemicals
This is a sustainable chemistry company that mass-produces levulinic acid as a greener alternative to traditional petrochemicals.
Arsenal
This is a prominent professional football club based in London that competes in the English Premier League.
The details
Flamini utilized his time off during his playing career at clubs like Arsenal and AC Milan to recruit experts and educate himself on the biochemical industry. The company focuses on the mass production of levulinic acid to create sustainable alternatives to oil-based products.
Timeline
2004: Mathieu Flamini signed for Arsenal.
2006: Mathieu Flamini featured in the Champions League final.
2013: Mathieu Flamini co-founded GF Biochemicals.
2020: Mathieu Flamini retired from professional football.
Season Trajectory
Flamini represents a significant departure from the trend of athletes pursuing standard brand endorsements or media roles. His move into industrial biochemistry sets a new benchmark for professional athletes diversifying into high-stakes, capital-intensive global sectors.
The valuation of GF Biochemicals at £10 billion places it in a unique bracket for businesses started by active professional athletes. Readers can observe this as an outlier case in professional sports history regarding long-term financial diversification.
The takeaway
Flamini demonstrates that athletes can cultivate expertise in complex scientific fields during their active playing years. His success suggests that strategic long-term planning outside of sport can lead to profound impacts in global industries.
Further reading
Learn more about high-profile athlete career transitions on the Soccer section.
Live Poll
Do you believe professional athletes should focus on business ventures during their playing careers?
